Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$272,459,544
+$28,914,145 QoQ
Shares Held
436,956
+38.6% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#33
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. REGN ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272,459,544 | 436,956 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $243,545,399 | 315,212 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $168,354,109 | 218,112 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $152,772,694 | 271,707 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $39,891,075 | 75,983 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,569,708 | 35,586 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,746,454 | 36,144 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $63,622,094 | 60,521 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $54,384,495 | 51,744 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $104,403,213 | 108,472 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $82,172,811 | 93,560 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,236,884 | 40,387 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $83,807,630 | 116,636 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,747,055 | 30,118 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $55,641,308 | 77,120 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,534,228 | 19,647 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,788,061 | 38,550 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $20,931,647 | 29,970 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $92,952,796 | 147,189 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,638,316 | 80,370 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,854,607 | 108,953 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $56,903,127 | 120,267 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $21,907,588 | 45,347 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,845,131 | 28,306 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $21,181,647 | 33,964 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,982,690 | 30,684 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||